首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1548060

全球寡核苷酸合成市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Oligonucleotide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 123 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到2032年，全球寡核苷酸合成市场的市场规模将从2023年的39.2亿美元达到近129.1亿美元，2024-2032年研究期间的复合年增长率为14.16%。

寡核苷酸合成是指化学合成具有确定的化学结构或各种大小的序列的核酸片段。这个过程能够产生自然界中不存在的基因。由于基因技术的进步，实验室合成寡核苷酸已成为现实。寡核苷酸在生物化学、分子诊断、基因组学和其他分子生物学应用等各个生物领域中受到追捧。这种合成技术的出现在很大程度上有助于癌症、肝炎和自体免疫抗体治疗的进步。分子生物学的进步对癌症疫苗开发、免疫治疗和早期检测提出了很高的期望。随着自动化能力的不断提高，对生物体基因组的有效操作将持续提高。

市场动态

由于製药和生物技术领域研究活动的增加，该市场出现显着成长。对创新诊断和治疗技术的需求不断增长，以及政府用于开发基因组技术的支出增加，也可以推动市场成长。由于资源缺乏、需求有限和成本限制，市场范围可能会缩小。缺乏在这一新兴领域进行研究的熟练人员可能会阻碍该市场的成长。该报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球寡核苷酸合成市场的每个细分市场进行了包容性评估。寡核苷酸合成产业的成长和趋势为本研究提供了整体方法。

市场区隔

寡核苷酸合成市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品和服务

寡核苷酸
设备/合成器
试剂
服务

按申请

PCR引子
PCR 检测与试剂盒
定序
DNA微阵列
萤光原位杂交 (FISH)
反义寡核苷酸
其他应用

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲寡核苷酸合成市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。寡核苷酸合成市场的主要参与者包括 Thermo Fisher Scientific Inc.、Merck KGaA、Danaher Corporation、Dharmacon Inc.、Agilent Technologies、Bio-Synthesis、Kaneka Eurogentec SA、LGC Biosearch Technologies、Biolegio、Twist Bioscience。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：寡核苷酸合成公司的竞争格局

寡核苷酸合成市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Thermo Fisher Scientific Inc.

公司概况
公司收入
产品
最新动态

Merck KGaA

公司概况
公司收入
产品
最新动态

Danaher Corporation

公司概况
公司收入
产品
最新动态

Dharmacon Inc.

公司概况
公司收入
产品
最新动态

Agilent Technologies

公司概况
公司收入
产品
最新动态

Bio-Synthesis

公司概况
公司收入
产品
最新动态

Kaneka Eurogentec SA

公司概况
公司收入
产品
最新动态

LGC Biosearch Technologies

公司概况
公司收入
产品
最新动态

Biolegio

公司概况
公司收入
产品
最新动态

Twist Bioscience

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11211903

The global demand for Oligonucleotide Synthesis Market is presumed to reach the market size of nearly USD 12.91 Billion by 2032 from USD 3.92 Billion in 2023 with a CAGR of 14.16% under the study period 2024-2032.

Oligonucleotide Synthesis refers to the chemical synthesis of nucleic acid fragments with defined chemical structures or sequences in various sizes. This process is capable of producing genes which are not existent in nature. The synthesis of oligonucleotide in the laboratory has become a reality due to the advancement in gene technology. Oligonucleotides are sought after in various biological sectors like biochemistry, molecular diagnostics, genomics, and other molecular biology applications. The advent of this synthesis technique has largely helped in advancements related to the treatment of cancer, hepatitis, and autoimmune antibodies. Improvement in molecular biology has set great expectancies related to cancer vaccine development, immunotherapy, and early detection. As automation capabilities continue to rise efficient manipulation of a living organism's genome will continue to improve.

MARKET DYNAMICS

There is a significant growth in this market due to increased research activities in the pharmaceuticals and biotechnology sectors. The rising demand for innovative diagnostic and therapeutic techniques and increased government spending for the development of genomic technologies also can fuel market growth. The market scope can be narrowed down due to a lack of resources, limited requirements and cost constraints. The lack of skilled personnel to carry out research in this newly emerging area can hinder the growth of this market. The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oligonucleotide Synthesis. The growth and trends of Oligonucleotide Synthesis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Oligonucleotide Synthesis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Oligonucleotides
Equipment/Synthesizer
Reagents
Services

By Application

PCR Primers
PCR Assays & Panels
Sequencing
DNA Microarrays
Fluorescence In Situ Hybridization (FISH)
Antisense Oligonucleotides
Other Applications

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Oligonucleotide Synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oligonucleotide Synthesis market include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Dharmacon Inc., Agilent Technologies, Bio-Synthesis, Kaneka Eurogentec S.A, LGC Biosearch Technologies, Biolegio, Twist Bioscience. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. OLIGONUCLEOTIDE SYNTHESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY PRODUCT & SERVICE

5.1. Overview By Product & Service
5.2. Historical and Forecast Data
5.3. Analysis By Product & Service
5.4. Oligonucleotides Historic and Forecast Sales By Regions
5.5. Equipment/Synthesizer Historic and Forecast Sales By Regions
5.6. Reagents Historic and Forecast Sales By Regions
5.7. Services Historic and Forecast Sales By Regions

6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. PCR Primers Historic and Forecast Sales By Regions
6.5. PCR Assays & Panels Historic and Forecast Sales By Regions
6.6. Sequencing Historic and Forecast Sales By Regions
6.7. DNA Microarrays Historic and Forecast Sales By Regions
6.8. Fluorescence In Situ Hybridization (FISH) Historic and Forecast Sales By Regions
6.9. Antisense Oligonucleotides Historic and Forecast Sales By Regions
6.10. Other Applications Historic and Forecast Sales By Regions

7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE OLIGONUCLEOTIDE SYNTHESIS COMPANIES

8.1. Oligonucleotide Synthesis Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF OLIGONUCLEOTIDE SYNTHESIS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Thermo Fisher Scientific Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Merck KGaA
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Dharmacon Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Agilent Technologies
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Bio-Synthesis
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Kaneka Eurogentec S.A
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. LGC Biosearch Technologies
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Biolegio
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Twist Bioscience
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments